|
|
Volumn 4, Issue 3, 2002, Pages 253-257
|
|
What's new in nicotine & tobacco research?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMFEBUTAMONE;
ANTIDEPRESSANT AGENT;
BROMOCRIPTINE;
CARBON MONOXIDE;
CIGARETTE SMOKE;
COTININE;
DNA;
DOPAMINE;
DOPAMINE RECEPTOR;
DOPAMINE RECEPTOR BLOCKING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
HALOPERIDOL;
NEUROTRANSMITTER;
NICOTINE;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
PLACEBO;
ADOLESCENCE;
ADOLESCENT;
ADULT;
ADULTHOOD;
AROUSAL;
CLINICAL RESEARCH;
COGNITION;
CONTROLLED STUDY;
COST;
COST CONTROL;
DATA ANALYSIS;
DEATH;
DOPAMINE RELEASE;
DOPAMINE UPTAKE;
EDITORIAL;
EDUCATION;
FEMALE;
GAS CHROMATOGRAPHY;
GENETIC PREDISPOSITION;
GROUP PSYCHOLOGY;
HEALTH BEHAVIOR;
HEALTH PROGRAM;
HEALTH STATUS;
HIGH SCHOOL;
HUMAN;
HYPERTENSION;
INHALATION;
LONGEVITY;
MALE;
NICOTINE REPLACEMENT THERAPY;
NONHUMAN;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REWARD;
SELF REPORT;
SMOKING;
SMOKING CESSATION;
TEST STRIP;
TOBACCO;
TOBACCO DEPENDENCE;
URINALYSIS;
VARIABLE NUMBER OF TANDEM REPEAT;
WITHDRAWAL SYNDROME;
|
|
EID: 0036671045
PISSN: 14622203
EISSN: None
Source Type: Journal
DOI: 10.1080/14622200210151508 Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
